Extradural Hematoma in Pediatrics After Acute Head Injury: Surgical and Clinical Outcome (NCT07696598) | Clinical Trial Compass
RecruitingNot Applicable
Extradural Hematoma in Pediatrics After Acute Head Injury: Surgical and Clinical Outcome
Egypt30 participantsStarted 2026-06-20
Plain-language summary
Acute extradural hematoma (EDH) is a potentially life-threatening neurosurgical emergency in children, commonly resulting from traumatic head injury. Early diagnosis and timely surgical intervention are critical factors influencing neurological recovery and overall outcome. Despite advances in neuroimaging and surgical techniques, the clinical presentation, management strategies, and outcomes of pediatric EDH remain variable
Who can participate
Age range
1 Day – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pediatric patients (\<18 years of age).
* Patients with traumatic extradural (epidural) hematoma.
* Patients who underwent surgical evacuation of the extradural hematoma.
Exclusion Criteria:
* Patients with coagulopathy.
* Patients with autoimmune disorders.
* Patients with a previous operation for extradural hematoma.
* Patients with associated intracranial hematomas (e.g., subdural hematoma, subarachnoid hemorrhage, or brain contusion).
* Patients with panfacial fractures.
* Patients with significant general surgical, cardiothoracic, or orthopedic comorbidit.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Neurological outcome assessed by the King's Outcome Scale for Childhood Head Injury (KOSCHI)
Timeframe: 3-6 month after surgery
Trial details
NCT IDNCT07696598
SponsorSohag University
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2027-01-01
Contact for this trial
abdelrahman mohamed neurosurgery department of sohag university, resident